These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7404129)
1. Measurement of human serum parathyroid hormone in disorders of calcium metabolism and during administration of certain gut hormones. Coetzee J; Klaff LJ; Epstein S S Afr Med J; 1980 Feb; 57(5):165-70. PubMed ID: 7404129 [TBL] [Abstract][Full Text] [Related]
2. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. Blind E; Schmidt-Gayk H; Scharla S; Flentje D; Fischer S; Göhring U; Hitzler W J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561 [TBL] [Abstract][Full Text] [Related]
3. [Intact serum parathormone (PTH 1-84). A suitable parameter for the diagnosis of calcium metabolism disorders]. Kruse K; Kracht U; Wohlfart K; Kruse U Dtsch Med Wochenschr; 1988 Feb; 113(8):283-8. PubMed ID: 3342739 [TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of a radioimmunoassay for parathyroid hormone in human serum. Almqvist S; Hjern B; Wästhed B Acta Endocrinol (Copenh); 1975 Mar; 78(3):493-509. PubMed ID: 1173015 [TBL] [Abstract][Full Text] [Related]
5. The use of an intact molecule parathyroid hormone assay in disorders of calcium metabolism. Bicknell EJ; Van't Hoff W Ann Clin Biochem; 1988 Jul; 25 ( Pt 4)():367-72. PubMed ID: 3063205 [TBL] [Abstract][Full Text] [Related]
6. [Calcium metabolism abnormalities and the levels of parathyroid hormone and calcitonin in the blood]. Fujita T Nihon Rinsho; 1972 Mar; 30(3):744-50. PubMed ID: 4558434 [No Abstract] [Full Text] [Related]
7. Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone. Minisola S; Scarnecchia L; Romagnoli E; Carnevale V; Pacitti MT; Scarda A; Rosso R; Mazzuoli GF J Endocrinol Invest; 1992; 15(7):483-9. PubMed ID: 1447486 [TBL] [Abstract][Full Text] [Related]
8. Regulation of circulating parathyroid hormone levels: normal physiology and consequences in disorders of mineral metabolism. Fischer JA; Blum JW; Hunziker W; Binswanger U Klin Wochenschr; 1975 Oct; 53(20):939-54. PubMed ID: 1202277 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease. Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients. Hackeng WH; Lips P; Netelenbos JC; Lips CJ J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025 [TBL] [Abstract][Full Text] [Related]
11. Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia. Vantini I; Cominacini L; Ederle A; Galvanini G; Piubello W; Adami S; Cavallini G; Lo Cascio V Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):472-7. PubMed ID: 549429 [TBL] [Abstract][Full Text] [Related]
12. A sensitive radioimmunoassay of parathyroid hormone in human serum using a specific extraction procedure. Christensen MS Scand J Clin Lab Invest; 1976 Jul; 36(4):313-22. PubMed ID: 959749 [TBL] [Abstract][Full Text] [Related]
13. Development and application of a mid-region specific assay for human parathyroid hormone. Gleed JH; Hendy GN; Nussbaum SR; Rosenblatt M; O'Riordan JL Clin Endocrinol (Oxf); 1986 Apr; 24(4):365-73. PubMed ID: 3742832 [TBL] [Abstract][Full Text] [Related]
14. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration. Dambacher MA; Fischer JA; Hunziker WH; Born W; Moran J; Roth HR; Delvin EE; Glorieux FH Clin Sci (Lond); 1979 Nov; 57(5):435-43. PubMed ID: 519952 [TBL] [Abstract][Full Text] [Related]
15. [Determination of intact parathyroid hormone in patients with calcium metabolism disorders]. Birkeland KI; Falch JA; Gautvik KM; Gjestvang FT; Holst N; Haug E Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1840-4. PubMed ID: 1853314 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic applicability of intact and midregion/C-terminal parathyroid hormone assays in calcium metabolic disorders. Rudnicki M; McNair P; Transbøl I; Lindgren P J Intern Med; 1990 Nov; 228(5):465-70. PubMed ID: 2254716 [TBL] [Abstract][Full Text] [Related]
17. Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism. Tohme JF; Bilezikian JP; Clemens TL; Silverberg SJ; Shane E; Lindsay R J Clin Endocrinol Metab; 1990 Apr; 70(4):951-6. PubMed ID: 2318950 [TBL] [Abstract][Full Text] [Related]
18. An adenylate cyclase bioassay for parathyroid hormone: some clinical experiences. Seshadri MS; Chan YL; Wilkinson MR; Mason RS; Posen S Clin Sci (Lond); 1985 Mar; 68(3):321-6. PubMed ID: 3971662 [TBL] [Abstract][Full Text] [Related]
19. Performance and clinical utility of a commercially available 'C-terminal' PTH assay. Ingle AR; Bailey JE; Matthews HL; Harrop JS Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():434-9. PubMed ID: 3767272 [TBL] [Abstract][Full Text] [Related]
20. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure. de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]